Elsmarieke van de Giessen

Citée par

	Toutes	Depuis 2020
Citations	3691	2262
indice h	28	22
indice i10	44	39

580

290

145

435

201020112012201320142015201620172018201920202021202220232024202533 48 50 106 129 162 189 210 227 227 266 351 428 532 566 106

Accès public

Tout afficher

49 articles

0 article

disponibles

non disponibles

Sur la base des exigences liées au financement

Coauteurs

Anissa Abi-DarghamProfessor of Psychiatry at Stony Brook University, Vice Chair for researchAdresse e-mail validée de stonybrookmedicine.edu
Lieuwe de HaanAdresse e-mail validée de amc.nl
Jodi J WeinsteinSUNY Stony Brook, SBUMC Dept of Psychiatry / Columbia University, CUMC Dept of PsychiatryAdresse e-mail validée de stonybrookmedicine.edu
Clifford CassidyAssistant Professor of Psychiatry, Stony Brook UniversityAdresse e-mail validée de cumc.columbia.edu
Guillermo HorgaAssociate Professor of Psychiatry, Columbia University and New York State Psychiatric InstituteAdresse e-mail validée de nyspi.columbia.edu
Valentina GaribottoGeneva University and Geneva University HospitalsAdresse e-mail validée de hcuge.ch
Silvia MorbelliNuclear Medicine, University of TurinAdresse e-mail validée de hsanmartino.it
Jared Van SnellenbergAssistant Professor of Psychiatry, Stony Brook University Renaissance School of MedicineAdresse e-mail validée de stonybrookmedicine.edu
Susanne E la FleurProfessor, Academic Medical Center - University of AmsterdamAdresse e-mail validée de amc.uva.nl
Swen HesseUniversität Leipzig, Molekulare Neurobildgebung IFB AdipositasErkrankungen, Klinik und PoliklinikAdresse e-mail validée de medizin.uni-leipzig.de
Jeffrey LiebermanProfessor of Psychiatry Columbia UniversityAdresse e-mail validée de columbia.edu
Richard E. CarsonProfessor of Radiology and Biomedical Imaging and of Biomedical EngineeringAdresse e-mail validée de yale.edu
Nabeel NabulsiDeputy Director of Chemistry, Yale School of MedicineAdresse e-mail validée de yale.edu
Javier ArbizuNuclear Medicine. Clínica Universidad de NavarraAdresse e-mail validée de unav.es
Ysbrand D. Van Der WerfDept Anatomy&Neurosciences, VU University medical centerAdresse e-mail validée de amsterdamumc.nl
Flavio NobiliUniversity of GenoaAdresse e-mail validée de hsanmartino.it
Koen Van Laere, MD PhD DrScHoogleraar KU LeuvenAdresse e-mail validée de telenet.be
Gitte Moos KnudsenRigshospitalet & University of CopenhagenAdresse e-mail validée de nru.dk
Rachel RosengardWeill Cornell Medical CollegeAdresse e-mail validée de med.cornell.edu
Pierre PayouxUT3 Professor, CHU Purpan, Tonic (INSERM-UT3), TMBI (Univ. Toulouse)Adresse e-mail validée de inserm.fr

Suivre

Elsmarieke van de Giessen

Post-doctoral researcher, Columbia University Medical Center

Adresse e-mail validée de columbia.edu

neuroimaging PET SPECT fMRI dopamine


Titre Trier par citations Trier par année Trier par titre	Citée par Citée par	Année
Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias G Chételat, J Arbizu, H Barthel, V Garibotto, I Law, S Morbelli, ... The Lancet Neurology 19 (11), 951-962, 2020	447	2020
Deficits in prefrontal cortical and extrastriatal dopamine release in schizophrenia: a positron emission tomographic functional magnetic resonance imaging study M Slifstein, E Van De Giessen, J Van Snellenberg, JL Thompson, ... JAMA psychiatry 72 (4), 316-324, 2015	446	2015
Baseline and amphetamine-stimulated dopamine activity are related in drug-naive schizophrenic subjects A Abi-Dargham, E van de Giessen, M Slifstein, LS Kegeles, M Laruelle Biological psychiatry 65 (12), 1091-1093, 2009	260	2009
Lower striatal dopamine D_2/3 receptor availability in obese compared with non-obese subjects BA de Weijer, E van de Giessen, TA van Amelsvoort, E Boot, B Braak, ... EJNMMI research 1, 1-5, 2011	216	2011
EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0 S Morbelli, G Esposito, J Arbizu, H Barthel, R Boellaard, NI Bohnen, ... European journal of nuclear medicine and molecular imaging 47, 1885-1912, 2020	204	2020
EANM procedure guidelines for brain PET imaging using [¹⁸F]FDG, version 3 E Guedj, A Varrone, R Boellaard, NL Albert, H Barthel, B van Berckel, ... European journal of nuclear medicine and molecular imaging, 1-20, 2022	195	2022
Striatal dopamine transporter availability associated with polymorphisms in the dopamine transporter gene SLC6A3 EM van de Giessen, MML de Win, MWT Tanck, W van den Brink, F Baas, ... Journal of Nuclear Medicine 50 (1), 45-52, 2009	179	2009
Deficits in striatal dopamine release in cannabis dependence E van de Giessen, JJ Weinstein, CM Cassidy, M Haney, Z Dong, ... Molecular psychiatry 22 (1), 68-75, 2017	165	2017
Mechanisms of working memory impairment in schizophrenia JX Van Snellenberg, RR Girgis, G Horga, E van de Giessen, M Slifstein, ... Biological psychiatry 80 (8), 617-626, 2016	140	2016
Reduced dopamine transporter binding predates impulse control disorders in Parkinson's disease C Vriend, AH Nordbeck, J Booij, YD van der Werf, T Pattij, P Voorn, ... Movement disorders 29 (7), 904-911, 2014	123	2014
Dopamine D_2/3 receptor availability and amphetamine-induced dopamine release in obesity E van de Giessen, F Celik, DH Schweitzer, W van den Brink, J Booij Journal of Psychopharmacology 28 (9), 866-873, 2014	95	2014
High fat/carbohydrate ratio but not total energy intake induces lower striatal dopamine D2/3 receptor availability in diet-induced obesity E Van de Giessen, SE La Fleur, L Eggels, K De Bruin, W Van Den Brink, ... International journal of obesity 37 (5), 754-757, 2013	83	2013
A Cochrane review on brain [¹⁸F]FDG PET in dementia: limitations and future perspectives S Morbelli, V Garibotto, E Van De Giessen, J Arbizu, G Chételat, ... European journal of nuclear medicine and molecular imaging 42, 1487-1491, 2015	77	2015
No association between striatal dopamine transporter binding and body mass index: A multi-center European study in healthy volunteers E de Giessen, S Hesse, MWA Caan, F Zientek, JC Dickson, L Tossici-Bolt, ... NeuroImage, 2012	75	2012
Free‐Choice and No‐Choice High‐Fat Diets Affect Striatal Dopamine D_2/3 Receptor Availability, Caloric Intake, and Adiposity E Van De Giessen, SE La Fleur, K De Bruin, W Van Den Brink, J Booij Obesity 20 (8), 1738-1740, 2012	64	2012
Striatal dopamine receptor binding in morbidly obese women before and after gastric bypass surgery and its relationship with insulin sensitivity BA de Weijer, E van de Giessen, I Janssen, FJ Berends, A van de Laar, ... Diabetologia 57, 1078-1080, 2014	59	2014
Striatal dopamine D2/3 receptor availability increases after long-term bariatric surgery-induced weight loss EM van der Zwaal, BA de Weijer, EM van de Giessen, I Janssen, ... European Neuropsychopharmacology 26 (7), 1190-1200, 2016	55	2016
The need of standardization and of large clinical studies in an emerging indication of [¹⁸F]FDG PET: the autoimmune encephalitis S Morbelli, J Arbizu, J Booij, MK Chen, G Chetelat, DJ Cross, M Djekidel, ... European journal of nuclear medicine and molecular imaging 44, 353-357, 2017	50	2017
Association of central serotonin transporter availability and body mass index in healthy Europeans S Hesse, E van de Giessen, F Zientek, D Petroff, K Winter, JC Dickson, ... European Neuropsychopharmacology 24 (8), 1240-1247, 2014	46	2014
Genetic polymorphisms in the DRD2, DRD3, and SLC6A3 gene in elderly patients with delirium BC van Munster, M Yazdanpanah, MWT Tanck, SEJA de Rooij, ... American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 153 …, 2010	44	2010

Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.

Articles 1–20

Nombre de citations par an

Citations en double

Citations fusionnées

Ajouter les coauteursCoauteurs

Suivre

Citée par

Coauteurs